期刊文献+

急性泛发性发疹性脓疱性皮病12例临床病理分析 被引量:12

Clinicopathological analysis of 12 cases of acute generalized exanthematous pustulosis
暂未订购
导出
摘要 目的了解急性泛发性发疹性脓疱性皮病AGEP的发病原因、临床病理特征及治疗情况。方法回顾性分析12例AGEP患者的临床资料。结果12例患者中2例有银屑病病史。男女发病之比为1∶3,平均发病年龄31.3岁。7例患者发病前有明确的用药史,4例有病毒或细菌感染史,11例患者有发热及白细胞和嗜中性粒细胞增多。AGEP病程短暂且有自限性。组织病理学检查示表皮内或角质层下脓疱和真皮浅层水肿。去除可能的发病因素药物和清除感染灶,给予中、小剂量的糖皮质激素口服或注射,患者基本痊愈。结论AGEP为一种较少见的疾病,多由药物引起,临床及病理上具有特征性,去除诱发因素和及时应用糖皮质激素是治疗的关键。 Objective: To explore the etiology, clinical and histological features and treatment in patients with acute generalized exanthematous pustulosis (AGEP). Methods: Twelve cases of acute generalized exanthematous pustulosis were analyzed retrospectively. Results: Two of these cases were occurred in patients with a history of psoriasis, the ratio of female to male was 3 to 1. The average age was 31.3 years old. Seven cases were drug-induced. four cases were followed virus or bacterial infection. Eleven cases had fever , leukocytosis and neutrophilia. Histopathological examination revealed spongiform superficial pustules and papillary edema. The precipitating factors ( the suspected drug and infection focus) were kept off and low-medium doses of steroids was administered, almost all patients were healed. Conclusion: AGEP is a rare but distinctive entity with the clincal and histopathological features.
机构地区 中国医学科学院
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2004年第2期89-91,共3页 Journal of Clinical Dermatology
关键词 脓疱性皮病 发疹性 急性泛发性 临床病理特征 acute generalized exanthematous pustulosis clinicopathological features
  • 相关文献

参考文献10

  • 1[1]De Coninck AL, Van Strubarq AS, Pipeleers-Marichal MA, et al. Acute generalized exanthematous pustulosis induced by paracetamol. A case with severe hemodynamic disturbances [J].Dermatology, 1996, 193(4): 338-341.
  • 2[2]Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases[J]. Arch Dermatol,1991, 127(9): 1333-1338.
  • 3[3]Sidoroff A, Halevy S, Bavinck JN, et al. Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern[J].J Cutan Pathol, 2001, 28(3): 113-119.
  • 4[4]Valks R, Fraga J, Munoz E, et al. Acute generalized exanthematous pustulosis in patients receiving high -dose chemotherapy[J]. Arch Dermatol, 1999, 135(11): 1418-1420.
  • 5[5]Aquilina C, Viraben R, Roueire A. Acute generalized exanthematous pustulosis: a cutaneous adverse effect due to prophylactic antiviral therapy with protease inhibitor [J]. Arch Intern Med, 1998, 158(19): 2160-2161.
  • 6[6]Britschgi M, Steiner UC, Schmid S, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis [J]. J Clin Invest, 2001, 107(11): 1433-1441.
  • 7[7]Ohtsuka T, Yamakage A, Yamazaki S. Acute generalized exanthematous pustulosis- An apoptotic process as suggested by immunohistochemical analysis?[J]. Dermatology, 1998, 197 (2):188-189.
  • 8[8]Schmid S, Kuechler PC, Britschgi M, et al. Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation[J]. Am J Pathol, 2002, 161(6): 2079-2086.
  • 9[9]Blodgett TP, Camisa C, Gay D, et al. Acute generalized exanthematous pustulosis secondary to diltiazem therapy[J]. Cutis,1997, 60(1): 45-47.
  • 10[10]Wolkenstein P, Chosidow O, Flechet ML, et al. Patch testing in severe cutaneous adverse drug reactions, including StevensJohnson syndrome and toxic epidermal necrolysis [J]. Contact Dermatitis, 1996, 35(4): 234-236.

同被引文献62

引证文献12

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部